Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-11-18 16:05:48
Reporting Period:
Filing Date:
Accepted Time:
2014-11-18 16:05:48
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1305253 Celladon Corp CLDN Biological Products, (No Disgnostic Substances) (2836) 330971591
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590705 J Jeffrey Rudy 11988 El Camino Real, Suite 650
San Diego CA 92130
Vp, Clinical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-14 18,000 $1.12 18,000 No 4 M Direct
Common Stock Disposition 2014-11-14 18,000 $11.67 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2014-11-14 18,000 $0.00 18,000 $1.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
121,738 2013-01-27 2022-06-14 No 4 M Direct
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.51 to $12.05 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. 25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.